SCHEMBL6318896

SCHEMBL6318896

Cc1ccc(Sc2nc(N)nc3nc[nH]c23)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K5 Q99683 1/20 0.61
PIN1 Q13526 3/20 0.53
POLB P06746 1/20 0.51
CYP2C19 P33261 6/20 0.50
CYP1A2 P05177 5/20 0.50
CYP3A4 P08684 4/20 0.50
CYP2C9 P11712 3/20 0.50
ALDH1A1 P00352 3/20 0.50
CYP2D6 P10635 3/20 0.50
HPGD P15428 2/20 0.50
HIF1A Q16665 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TOP2A P11388 1/20 0.50
NUDT1 P36639 1/20 0.50
PDPK1 O15530 1/20 0.49
GDA Q9Y2T3 1/20 0.49
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 2/20 0.46
HBB P68871 2/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6321254 0.86 MAP3K5 (0.57) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL3305057 0.80 PIN1 (0.76) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL6318891 0.77 EGFR (0.41) MAP3K5PIN1CYP2C19CYP1A2CYP3A4
SCHEMBL94363 0.77 MAP3K5 (1.00) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL9346526 0.75 MAP3K5 (0.72) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL16758710 0.73 MAP3K5 (0.69) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL320850 0.71 PDPK1 (0.66) MAP3K5PIN1CYP1A2PDPK1GDA
SCHEMBL7806465 0.70 PIN1 (0.60) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL2891519 0.70 MAP3K5 (0.64) MAP3K5PIN1POLBCYP2C19CYP1A2
SCHEMBL3297931 0.69 PIN1 (1.00) PIN1CYP2C19CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050215787-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF PURINES COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2005-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050215787-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF PURINES PNP, HPRT1, NUDT1 MAP3K5 3423/4885PIN1 4378/4885POLB 322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.